Global Oral Contraceptive Drugs

Oral Contraceptive Drugs Comprehensive Study by Type (Long-acting Contraceptives, Short-acting Contraceptives, Emergency Contraceptives), Application (Hospital, Pharmacy, Other), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2026

Oral Contraceptive Drugs Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Oral contraceptive drugs are is pill used to prevent unwanted pregnancy by blocking the normal process of ovulation or by altering the process which supports the fertilization of an egg. Pills include progestin and estrogen hormones. The market for birth control pills is increasing owing to the growing need for population control and increasing incidents of abortion.This growth is primarily driven by High Incident Rate of Unintended Pregnancy, An Increasing need for Population Control and Increasing Incident of Abortion and Ease of Use and Low Cost of Oral Contraceptive Drugs.

Globally, a noticeable market trend is evident Increasing Maternal age and Late pregnancies. Major Players, such as Merck (United States), Pfizer (United States), Teva Pharmaceutical (Israel), Actavis (United States), Johnson & Johnson (United States), Gedeon Richter (Hungary) and Novo Nordisk A/S (Denmark) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:

In July 2019, Lyndra Therapeutics (the US), a leading pharmaceutical product company, announced the receiving of USD 13 MN grant from Bill and Melinda Gates Foundation toward the development of a once-a-month oral contraceptive

Regulatory Insights:
According to the centers for disease control and prevention, in 2017, it was estimated that about 194,377 babies were born to women, aged 15-19 years, for a birth rate of 18.8 per 1,000 women, in this age group.

Market Drivers
  • High Incident Rate of Unintended Pregnancy
  • An Increasing need for Population Control and Increasing Incident of Abortion
  • Ease of Use and Low Cost of Oral Contraceptive Drugs

Market Trend
  • Increasing Maternal age and Late pregnancies

Restraints
  • Side Effects Associated with the Use of Oral Contraceptive Drugs of High Dosage
  • Increased Usage of Alternative Birth Control Method


Challenges
Rising Occurrence of Infertility amongst Women is Restricting the Use of Drug

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Oral Contraceptive Drugs Study Sheds Light on
— The Oral Contraceptive Drugs Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Oral Contraceptive Drugs industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Oral Contraceptive Drugs industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Long-acting Contraceptives
  • Short-acting Contraceptives
  • Emergency Contraceptives
By Application
  • Hospital
  • Pharmacy
  • Other
By Distribution Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. High Incident Rate of Unintended Pregnancy
      • 3.2.2. An Increasing need for Population Control and Increasing Incident of Abortion
      • 3.2.3. Ease of Use and Low Cost of Oral Contraceptive Drugs
    • 3.3. Market Challenges
      • 3.3.1. Rising Occurrence of Infertility amongst Women is Restricting the Use of Drug
    • 3.4. Market Trends
      • 3.4.1. Increasing Maternal age and Late pregnancies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Oral Contraceptive Drugs, by Type, Application, Distribution Channel and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Oral Contraceptive Drugs (Value)
      • 5.2.1. Global Oral Contraceptive Drugs by: Type (Value)
        • 5.2.1.1. Long-acting Contraceptives
        • 5.2.1.2. Short-acting Contraceptives
        • 5.2.1.3. Emergency Contraceptives
      • 5.2.2. Global Oral Contraceptive Drugs by: Application (Value)
        • 5.2.2.1. Hospital
        • 5.2.2.2. Pharmacy
        • 5.2.2.3. Other
      • 5.2.3. Global Oral Contraceptive Drugs by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Oral Contraceptive Drugs Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Oral Contraceptive Drugs (Volume)
      • 5.3.1. Global Oral Contraceptive Drugs by: Type (Volume)
        • 5.3.1.1. Long-acting Contraceptives
        • 5.3.1.2. Short-acting Contraceptives
        • 5.3.1.3. Emergency Contraceptives
      • 5.3.2. Global Oral Contraceptive Drugs by: Application (Volume)
        • 5.3.2.1. Hospital
        • 5.3.2.2. Pharmacy
        • 5.3.2.3. Other
      • 5.3.3. Global Oral Contraceptive Drugs by: Distribution Channel (Volume)
        • 5.3.3.1. Online
        • 5.3.3.2. Offline
      • 5.3.4. Global Oral Contraceptive Drugs Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Oral Contraceptive Drugs (Price)
      • 5.4.1. Global Oral Contraceptive Drugs by: Type (Price)
  • 6. Oral Contraceptive Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Merck (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Teva Pharmaceutical (Israel)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Actavis (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson & Johnson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gedeon Richter (Hungary)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Novo Nordisk A/S (Denmark)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
  • 7. Global Oral Contraceptive Drugs Sale, by Type, Application, Distribution Channel and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Oral Contraceptive Drugs (Value)
      • 7.2.1. Global Oral Contraceptive Drugs by: Type (Value)
        • 7.2.1.1. Long-acting Contraceptives
        • 7.2.1.2. Short-acting Contraceptives
        • 7.2.1.3. Emergency Contraceptives
      • 7.2.2. Global Oral Contraceptive Drugs by: Application (Value)
        • 7.2.2.1. Hospital
        • 7.2.2.2. Pharmacy
        • 7.2.2.3. Other
      • 7.2.3. Global Oral Contraceptive Drugs by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Oral Contraceptive Drugs Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Oral Contraceptive Drugs (Volume)
      • 7.3.1. Global Oral Contraceptive Drugs by: Type (Volume)
        • 7.3.1.1. Long-acting Contraceptives
        • 7.3.1.2. Short-acting Contraceptives
        • 7.3.1.3. Emergency Contraceptives
      • 7.3.2. Global Oral Contraceptive Drugs by: Application (Volume)
        • 7.3.2.1. Hospital
        • 7.3.2.2. Pharmacy
        • 7.3.2.3. Other
      • 7.3.3. Global Oral Contraceptive Drugs by: Distribution Channel (Volume)
        • 7.3.3.1. Online
        • 7.3.3.2. Offline
      • 7.3.4. Global Oral Contraceptive Drugs Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Oral Contraceptive Drugs (Price)
      • 7.4.1. Global Oral Contraceptive Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Oral Contraceptive Drugs: by Type(USD Million)
  • Table 2. Oral Contraceptive Drugs Long-acting Contraceptives , by Region USD Million (2015-2020)
  • Table 3. Oral Contraceptive Drugs Short-acting Contraceptives , by Region USD Million (2015-2020)
  • Table 4. Oral Contraceptive Drugs Emergency Contraceptives , by Region USD Million (2015-2020)
  • Table 5. Oral Contraceptive Drugs: by Application(USD Million)
  • Table 6. Oral Contraceptive Drugs Hospital , by Region USD Million (2015-2020)
  • Table 7. Oral Contraceptive Drugs Pharmacy , by Region USD Million (2015-2020)
  • Table 8. Oral Contraceptive Drugs Other , by Region USD Million (2015-2020)
  • Table 9. Oral Contraceptive Drugs: by Distribution Channel(USD Million)
  • Table 10. Oral Contraceptive Drugs Online , by Region USD Million (2015-2020)
  • Table 11. Oral Contraceptive Drugs Offline , by Region USD Million (2015-2020)
  • Table 12. South America Oral Contraceptive Drugs, by Country USD Million (2015-2020)
  • Table 13. South America Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 14. South America Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 15. South America Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 16. Brazil Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 17. Brazil Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 18. Brazil Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 19. Argentina Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 20. Argentina Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 21. Argentina Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 22. Rest of South America Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 23. Rest of South America Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 24. Rest of South America Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 25. Asia Pacific Oral Contraceptive Drugs, by Country USD Million (2015-2020)
  • Table 26. Asia Pacific Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 27. Asia Pacific Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 28. Asia Pacific Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 29. China Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 30. China Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 31. China Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 32. Japan Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 33. Japan Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 34. Japan Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 35. India Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 36. India Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 37. India Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 38. South Korea Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 39. South Korea Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 40. South Korea Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 41. Taiwan Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 42. Taiwan Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 43. Taiwan Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 44. Australia Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 45. Australia Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 46. Australia Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 47. Rest of Asia-Pacific Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 48. Rest of Asia-Pacific Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 49. Rest of Asia-Pacific Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 50. Europe Oral Contraceptive Drugs, by Country USD Million (2015-2020)
  • Table 51. Europe Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 52. Europe Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 53. Europe Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 54. Germany Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 55. Germany Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 56. Germany Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 57. France Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 58. France Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 59. France Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 60. Italy Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 61. Italy Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 62. Italy Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 63. United Kingdom Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 64. United Kingdom Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 65. United Kingdom Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 66. Netherlands Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 67. Netherlands Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 68. Netherlands Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 69. Rest of Europe Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 70. Rest of Europe Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 71. Rest of Europe Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 72. MEA Oral Contraceptive Drugs, by Country USD Million (2015-2020)
  • Table 73. MEA Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 74. MEA Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 75. MEA Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 76. Middle East Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 77. Middle East Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 78. Middle East Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 79. Africa Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 80. Africa Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 81. Africa Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 82. North America Oral Contraceptive Drugs, by Country USD Million (2015-2020)
  • Table 83. North America Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 84. North America Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 85. North America Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 86. United States Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 87. United States Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 88. United States Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 89. Canada Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 90. Canada Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 91. Canada Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 92. Mexico Oral Contraceptive Drugs, by Type USD Million (2015-2020)
  • Table 93. Mexico Oral Contraceptive Drugs, by Application USD Million (2015-2020)
  • Table 94. Mexico Oral Contraceptive Drugs, by Distribution Channel USD Million (2015-2020)
  • Table 95. Oral Contraceptive Drugs Sales: by Type(K Units)
  • Table 96. Oral Contraceptive Drugs Sales Long-acting Contraceptives , by Region K Units (2015-2020)
  • Table 97. Oral Contraceptive Drugs Sales Short-acting Contraceptives , by Region K Units (2015-2020)
  • Table 98. Oral Contraceptive Drugs Sales Emergency Contraceptives , by Region K Units (2015-2020)
  • Table 99. Oral Contraceptive Drugs Sales: by Application(K Units)
  • Table 100. Oral Contraceptive Drugs Sales Hospital , by Region K Units (2015-2020)
  • Table 101. Oral Contraceptive Drugs Sales Pharmacy , by Region K Units (2015-2020)
  • Table 102. Oral Contraceptive Drugs Sales Other , by Region K Units (2015-2020)
  • Table 103. Oral Contraceptive Drugs Sales: by Distribution Channel(K Units)
  • Table 104. Oral Contraceptive Drugs Sales Online , by Region K Units (2015-2020)
  • Table 105. Oral Contraceptive Drugs Sales Offline , by Region K Units (2015-2020)
  • Table 106. South America Oral Contraceptive Drugs Sales, by Country K Units (2015-2020)
  • Table 107. South America Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 108. South America Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 109. South America Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 110. Brazil Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 111. Brazil Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 112. Brazil Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 113. Argentina Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 114. Argentina Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 115. Argentina Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 116. Rest of South America Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 117. Rest of South America Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 118. Rest of South America Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 119. Asia Pacific Oral Contraceptive Drugs Sales, by Country K Units (2015-2020)
  • Table 120. Asia Pacific Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 121. Asia Pacific Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 122. Asia Pacific Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 123. China Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 124. China Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 125. China Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 126. Japan Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 127. Japan Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 128. Japan Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 129. India Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 130. India Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 131. India Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 132. South Korea Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 133. South Korea Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 134. South Korea Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 135. Taiwan Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 136. Taiwan Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 137. Taiwan Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 138. Australia Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 139. Australia Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 140. Australia Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 141. Rest of Asia-Pacific Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 142. Rest of Asia-Pacific Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 143. Rest of Asia-Pacific Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 144. Europe Oral Contraceptive Drugs Sales, by Country K Units (2015-2020)
  • Table 145. Europe Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 146. Europe Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 147. Europe Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 148. Germany Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 149. Germany Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 150. Germany Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 151. France Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 152. France Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 153. France Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 154. Italy Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 155. Italy Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 156. Italy Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 157. United Kingdom Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 158. United Kingdom Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 159. United Kingdom Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 160. Netherlands Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 161. Netherlands Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 162. Netherlands Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 163. Rest of Europe Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 164. Rest of Europe Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 165. Rest of Europe Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 166. MEA Oral Contraceptive Drugs Sales, by Country K Units (2015-2020)
  • Table 167. MEA Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 168. MEA Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 169. MEA Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 170. Middle East Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 171. Middle East Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 172. Middle East Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 173. Africa Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 174. Africa Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 175. Africa Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 176. North America Oral Contraceptive Drugs Sales, by Country K Units (2015-2020)
  • Table 177. North America Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 178. North America Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 179. North America Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 180. United States Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 181. United States Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 182. United States Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 183. Canada Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 184. Canada Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 185. Canada Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 186. Mexico Oral Contraceptive Drugs Sales, by Type K Units (2015-2020)
  • Table 187. Mexico Oral Contraceptive Drugs Sales, by Application K Units (2015-2020)
  • Table 188. Mexico Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2015-2020)
  • Table 189. Oral Contraceptive Drugs: by Type(USD/Units)
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Oral Contraceptive Drugs: by Type(USD Million)
  • Table 198. Oral Contraceptive Drugs Long-acting Contraceptives , by Region USD Million (2021-2026)
  • Table 199. Oral Contraceptive Drugs Short-acting Contraceptives , by Region USD Million (2021-2026)
  • Table 200. Oral Contraceptive Drugs Emergency Contraceptives , by Region USD Million (2021-2026)
  • Table 201. Oral Contraceptive Drugs: by Application(USD Million)
  • Table 202. Oral Contraceptive Drugs Hospital , by Region USD Million (2021-2026)
  • Table 203. Oral Contraceptive Drugs Pharmacy , by Region USD Million (2021-2026)
  • Table 204. Oral Contraceptive Drugs Other , by Region USD Million (2021-2026)
  • Table 205. Oral Contraceptive Drugs: by Distribution Channel(USD Million)
  • Table 206. Oral Contraceptive Drugs Online , by Region USD Million (2021-2026)
  • Table 207. Oral Contraceptive Drugs Offline , by Region USD Million (2021-2026)
  • Table 208. South America Oral Contraceptive Drugs, by Country USD Million (2021-2026)
  • Table 209. South America Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 210. South America Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 211. South America Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 212. Brazil Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 213. Brazil Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 214. Brazil Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 215. Argentina Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 216. Argentina Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 217. Argentina Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 218. Rest of South America Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 219. Rest of South America Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 220. Rest of South America Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 221. Asia Pacific Oral Contraceptive Drugs, by Country USD Million (2021-2026)
  • Table 222. Asia Pacific Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 223. Asia Pacific Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 224. Asia Pacific Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 225. China Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 226. China Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 227. China Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 228. Japan Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 229. Japan Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 230. Japan Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 231. India Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 232. India Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 233. India Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 234. South Korea Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 235. South Korea Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 236. South Korea Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 237. Taiwan Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 238. Taiwan Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 239. Taiwan Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 240. Australia Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 241. Australia Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 242. Australia Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 243. Rest of Asia-Pacific Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 244. Rest of Asia-Pacific Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 245. Rest of Asia-Pacific Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 246. Europe Oral Contraceptive Drugs, by Country USD Million (2021-2026)
  • Table 247. Europe Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 248. Europe Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 249. Europe Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 250. Germany Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 251. Germany Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 252. Germany Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 253. France Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 254. France Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 255. France Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 256. Italy Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 257. Italy Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 258. Italy Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 259. United Kingdom Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 260. United Kingdom Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 261. United Kingdom Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 262. Netherlands Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 263. Netherlands Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 264. Netherlands Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 265. Rest of Europe Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 266. Rest of Europe Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 267. Rest of Europe Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 268. MEA Oral Contraceptive Drugs, by Country USD Million (2021-2026)
  • Table 269. MEA Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 270. MEA Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 271. MEA Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 272. Middle East Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 273. Middle East Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 274. Middle East Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 275. Africa Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 276. Africa Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 277. Africa Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 278. North America Oral Contraceptive Drugs, by Country USD Million (2021-2026)
  • Table 279. North America Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 280. North America Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 281. North America Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 282. United States Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 283. United States Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 284. United States Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 285. Canada Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 286. Canada Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 287. Canada Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 288. Mexico Oral Contraceptive Drugs, by Type USD Million (2021-2026)
  • Table 289. Mexico Oral Contraceptive Drugs, by Application USD Million (2021-2026)
  • Table 290. Mexico Oral Contraceptive Drugs, by Distribution Channel USD Million (2021-2026)
  • Table 291. Oral Contraceptive Drugs Sales: by Type(K Units)
  • Table 292. Oral Contraceptive Drugs Sales Long-acting Contraceptives , by Region K Units (2021-2026)
  • Table 293. Oral Contraceptive Drugs Sales Short-acting Contraceptives , by Region K Units (2021-2026)
  • Table 294. Oral Contraceptive Drugs Sales Emergency Contraceptives , by Region K Units (2021-2026)
  • Table 295. Oral Contraceptive Drugs Sales: by Application(K Units)
  • Table 296. Oral Contraceptive Drugs Sales Hospital , by Region K Units (2021-2026)
  • Table 297. Oral Contraceptive Drugs Sales Pharmacy , by Region K Units (2021-2026)
  • Table 298. Oral Contraceptive Drugs Sales Other , by Region K Units (2021-2026)
  • Table 299. Oral Contraceptive Drugs Sales: by Distribution Channel(K Units)
  • Table 300. Oral Contraceptive Drugs Sales Online , by Region K Units (2021-2026)
  • Table 301. Oral Contraceptive Drugs Sales Offline , by Region K Units (2021-2026)
  • Table 302. South America Oral Contraceptive Drugs Sales, by Country K Units (2021-2026)
  • Table 303. South America Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 304. South America Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 305. South America Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 306. Brazil Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 307. Brazil Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 308. Brazil Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 309. Argentina Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 310. Argentina Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 311. Argentina Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 312. Rest of South America Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 313. Rest of South America Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 314. Rest of South America Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 315. Asia Pacific Oral Contraceptive Drugs Sales, by Country K Units (2021-2026)
  • Table 316. Asia Pacific Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 317. Asia Pacific Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 318. Asia Pacific Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 319. China Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 320. China Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 321. China Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 322. Japan Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 323. Japan Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 324. Japan Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 325. India Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 326. India Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 327. India Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 328. South Korea Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 329. South Korea Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 330. South Korea Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 331. Taiwan Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 332. Taiwan Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 333. Taiwan Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 334. Australia Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 335. Australia Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 336. Australia Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 337. Rest of Asia-Pacific Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 338. Rest of Asia-Pacific Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 339. Rest of Asia-Pacific Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 340. Europe Oral Contraceptive Drugs Sales, by Country K Units (2021-2026)
  • Table 341. Europe Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 342. Europe Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 343. Europe Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 344. Germany Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 345. Germany Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 346. Germany Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 347. France Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 348. France Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 349. France Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 350. Italy Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 351. Italy Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 352. Italy Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 353. United Kingdom Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 354. United Kingdom Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 355. United Kingdom Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 356. Netherlands Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 357. Netherlands Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 358. Netherlands Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 359. Rest of Europe Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 360. Rest of Europe Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 361. Rest of Europe Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 362. MEA Oral Contraceptive Drugs Sales, by Country K Units (2021-2026)
  • Table 363. MEA Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 364. MEA Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 365. MEA Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 366. Middle East Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 367. Middle East Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 368. Middle East Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 369. Africa Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 370. Africa Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 371. Africa Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 372. North America Oral Contraceptive Drugs Sales, by Country K Units (2021-2026)
  • Table 373. North America Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 374. North America Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 375. North America Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 376. United States Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 377. United States Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 378. United States Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 379. Canada Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 380. Canada Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 381. Canada Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 382. Mexico Oral Contraceptive Drugs Sales, by Type K Units (2021-2026)
  • Table 383. Mexico Oral Contraceptive Drugs Sales, by Application K Units (2021-2026)
  • Table 384. Mexico Oral Contraceptive Drugs Sales, by Distribution Channel K Units (2021-2026)
  • Table 385. Oral Contraceptive Drugs: by Type(USD/Units)
  • Table 386. Research Programs/Design for This Report
  • Table 387. Key Data Information from Secondary Sources
  • Table 388. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Oral Contraceptive Drugs: by Type USD Million (2015-2020)
  • Figure 5. Global Oral Contraceptive Drugs: by Application USD Million (2015-2020)
  • Figure 6. Global Oral Contraceptive Drugs: by Distribution Channel USD Million (2015-2020)
  • Figure 7. South America Oral Contraceptive Drugs Share (%), by Country
  • Figure 8. Asia Pacific Oral Contraceptive Drugs Share (%), by Country
  • Figure 9. Europe Oral Contraceptive Drugs Share (%), by Country
  • Figure 10. MEA Oral Contraceptive Drugs Share (%), by Country
  • Figure 11. North America Oral Contraceptive Drugs Share (%), by Country
  • Figure 12. Global Oral Contraceptive Drugs: by Type K Units (2015-2020)
  • Figure 13. Global Oral Contraceptive Drugs: by Application K Units (2015-2020)
  • Figure 14. Global Oral Contraceptive Drugs: by Distribution Channel K Units (2015-2020)
  • Figure 15. South America Oral Contraceptive Drugs Share (%), by Country
  • Figure 16. Asia Pacific Oral Contraceptive Drugs Share (%), by Country
  • Figure 17. Europe Oral Contraceptive Drugs Share (%), by Country
  • Figure 18. MEA Oral Contraceptive Drugs Share (%), by Country
  • Figure 19. North America Oral Contraceptive Drugs Share (%), by Country
  • Figure 20. Global Oral Contraceptive Drugs: by Type USD/Units (2015-2020)
  • Figure 21. Global Oral Contraceptive Drugs share by Players 2020 (%)
  • Figure 22. Global Oral Contraceptive Drugs share by Players (Top 3) 2020(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 25. Merck (United States) Revenue: by Geography 2020
  • Figure 26. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 27. Pfizer (United States) Revenue: by Geography 2020
  • Figure 28. Teva Pharmaceutical (Israel) Revenue, Net Income and Gross profit
  • Figure 29. Teva Pharmaceutical (Israel) Revenue: by Geography 2020
  • Figure 30. Actavis (United States) Revenue, Net Income and Gross profit
  • Figure 31. Actavis (United States) Revenue: by Geography 2020
  • Figure 32. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 33. Johnson & Johnson (United States) Revenue: by Geography 2020
  • Figure 34. Gedeon Richter (Hungary) Revenue, Net Income and Gross profit
  • Figure 35. Gedeon Richter (Hungary) Revenue: by Geography 2020
  • Figure 36. Novo Nordisk A/S (Denmark) Revenue, Net Income and Gross profit
  • Figure 37. Novo Nordisk A/S (Denmark) Revenue: by Geography 2020
  • Figure 38. Global Oral Contraceptive Drugs: by Type USD Million (2021-2026)
  • Figure 39. Global Oral Contraceptive Drugs: by Application USD Million (2021-2026)
  • Figure 40. Global Oral Contraceptive Drugs: by Distribution Channel USD Million (2021-2026)
  • Figure 41. South America Oral Contraceptive Drugs Share (%), by Country
  • Figure 42. Asia Pacific Oral Contraceptive Drugs Share (%), by Country
  • Figure 43. Europe Oral Contraceptive Drugs Share (%), by Country
  • Figure 44. MEA Oral Contraceptive Drugs Share (%), by Country
  • Figure 45. North America Oral Contraceptive Drugs Share (%), by Country
  • Figure 46. Global Oral Contraceptive Drugs: by Type K Units (2021-2026)
  • Figure 47. Global Oral Contraceptive Drugs: by Application K Units (2021-2026)
  • Figure 48. Global Oral Contraceptive Drugs: by Distribution Channel K Units (2021-2026)
  • Figure 49. South America Oral Contraceptive Drugs Share (%), by Country
  • Figure 50. Asia Pacific Oral Contraceptive Drugs Share (%), by Country
  • Figure 51. Europe Oral Contraceptive Drugs Share (%), by Country
  • Figure 52. MEA Oral Contraceptive Drugs Share (%), by Country
  • Figure 53. North America Oral Contraceptive Drugs Share (%), by Country
  • Figure 54. Global Oral Contraceptive Drugs: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Merck (United States)
  • Pfizer (United States)
  • Teva Pharmaceutical (Israel)
  • Actavis (United States)
  • Johnson & Johnson (United States)
  • Gedeon Richter (Hungary)
  • Novo Nordisk A/S (Denmark)
Additional players considered in the study are as follows:
ZiZhu , Baijingyu , Huazhong
Select User Access Type

Key Highlights of Report


Jan 2022 237 Pages 86 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Oral Contraceptive Drugs Quantitative research analysis
Global Oral Contraceptive Drugs Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026
Companies that are profiled in Global Oral Contraceptive Drugs Market are Merck (United States), Pfizer (United States), Teva Pharmaceutical (Israel), Actavis (United States), Johnson & Johnson (United States), Gedeon Richter (Hungary) and Novo Nordisk A/S (Denmark) etc.
Oral contraceptive drugs are is pill used to prevent unwanted pregnancy by blocking the normal process of ovulation or by altering the process which supports the fertilization of an egg. Pills include progestin and estrogen hormones. The market for birth control pills is increasing owing to the growing need for population control and increasing incidents of abortion.

Know More About Global Oral Contraceptive Drugs Report?

Have a Query? Click Here

Other Related Reports

Custom Antibody Comprehensive Study by Type (Monoclonal, Polyclonal, Recombinant), End-Users (Hospitals and Clinics, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract...
$ 3650
Pemetrexed Drug Comprehensive Study by Application (Pleural mesothelioma, Lung Cancer, Colorectal Cancer, Stomach Cancer, Breast Cancer), Distribution Channel (Online, Offline), Strength (100 mg lyop...
$ 3450
Trazodone Hydrochloride Comprehensive Study by Type (Tablet, Capsule), Application (Antidepression, Anxiolytic, Hypnotic, Others), (), Depression (Major Depression, Bipolar Disorder, Psychotic Depr...
$ 3650
Pain Management Drugs Comprehensive Study by Type (Generic Opioids, Branded Opioids), Application (Burn Pain, Cancer Pain, Dental/Facial Pain, Migraine Headache Pain, Musculoskeletal Pain, Neuropathi...
$ 3750
Acromegaly and Gigantism Drugs Comprehensive Study by Type (Somatostatin Analogs, GH Receptor Antagonists, Dopamine Agonists, Recombinant Human IGF-1), Distribution Channel (Retail Pharmacies, Hospit...
$ 3350
DPT Vaccines Comprehensive Study by Type (DPaT, DTwP, Tdap), Application (Diphtheria, Tetanus, Pertussis, Others), Vaccine Type (Whole-Cell Vaccine, Acellular Vaccine), End-User (Adult, Pediatric) Pl...
$ 3500